Back to search

United Kingdom· GB-APID-3461511000001104

Imazin XL forte tablets

A medicinal product containing aspirin + isosorbide mononitrate, registered in United Kingdom by Napp Pharmaceuticals Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedImazin XL forte tabletsATC—REGISTER NO.GB-APID-3461511000001…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Aspirin + Isosorbide mononitrate
Manufacturer
Napp Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/22107525-b99b-496e-a005-2b89abaea050
GET /v1/drugs/22107525-b99b-496e-a005-2b89abaea050?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3461511000001104",
  "desc": "Imazin XL forte tablets (Napp Pharmaceuticals Ltd)",
  "form": "Modified-release tablet",
  "vpid": "35903011000001102",
  "source": "dmd",
  "vtm_id": "1208366007",
  "strength": "150 mg",
  "substance": "Aspirin + Isosorbide mononitrate",
  "ingredient": "Aspirin",
  "supplier_code": "3592811000001102"
}

See everything about aspirin + isosorbide mononitrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.